October 27, 2023 01:33 PM EDT
Pharma
FDA+

CMS to kick off Medicare drug price ne­go­ti­a­tion lis­ten­ing ses­sions next week

Lia DeGroot

As CMS and phar­ma com­pa­nies pre­pare to hash out the first round of Medicare drug price ne­go­ti­a­tion pro­vi­sions of the In­fla­tion Re­duc­tion Act, CMS will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

Bris­tol My­ers pays $100M up­front to col­lab­o­rate with Leqem­bi orig­i­na­tor in Alzheimer's

A service from the Financial Times